Private equity firm Hony Capital divested an 11% stake in CSPC Pharmaceutical after Thursday's close in Hong Kong, raising HK$4.095 billion (US$528 million) from the sale of 650 million secondary shares.
¬ Haymarket Media Limited. All rights reserved.